International

Inter Mobility Grant 2021-1

Beca de intercambio de investigadores posdoctorales con instituciones públicas de Luxemburgo.

ERA-NET Euronanomed: Joint Transnational Call for Proposals (2021) for “European Innovative Research & Technological Development Projects in Nanomedicine”

1st Open Call GATEKEEPER Project

Engage actively new technology members in the GATEKEEPER Ecosystem, supplying new AI and Big Data applications, tools or components which will be incorporated in the technology offering portfolio of GATEKEEPER to Pilots and Platform designers and developers

13th Call Joint Programming Initiative on Antimicrobial Resistance – JPIAMR “One Health interventions to prevent or reduce the development and transmission of AMR” (Pre-announcement)

Multi-site COVID-19 related clinical trial implementation grant 2020

Ayudas para financiar ensayos clínicos multicéntricos relacionados con el envejecimiento y COVID-19.

Sarcoma Foundation of America Grant 2021

Ayudas para financiar proyectos de investigación sobre etiología, biología molecular, patogénesis, diagnóstico y tratamiento de sarcomas. Topics:

• Immunotherapy.
• Omic characterization of sarcomas and definition of novel targets.
• Omic patterns of sensitivity and resistance to existing agents.
• Systemic therapy combinations.
• Gene Therapy.

EFSD and NOVO Nordisk A/S Programme for Diabetes Research in Europe 2021

Ayudas para financiar un proyecto de investigación básica o clínica sobre diabetes.

• Neuroimaging and CSF Biomarkeer Development Program 2021-1
• Drug Development Program 2021-1
• Prevention Beyond the Pipeline 2021-1
• Program to Accelerate Clinical Trials (PACT) 2021-1
• The Treat FTD Fund 2021

Hollis Brownstein Research Grants Program 2021

Ayudas para financiar proyectos de investigación en etapas tempranas de la carrera investigadora sobre cáncer de células sanguíneas, incluyendo leucemia, linfoma, mieloma múltiple y el Síndrome mielodisplásico (MDS).

The Treat Fund 2021

Ayudas para financiar estudios clínicos relacionados con demencia frontotemporal (FTM):

• Biological mechanisms that have a sound scientific rationale for FTD.
• Suitable clinical trial designs, that may include features such as basket trials, adaptive study designs or other novel approaches.
• Biomarkers that can indicate target engagement and/or downstream pharmacologic effects.
• Biomarker endpoints that can provide a deeper understanding of the drug mechanism and disease progression.